Beacon Securities forecastCooper thinks Viemed will post EBITDA of (All figures USD) $22.8-million on revenue of $83.9-million in fiscal 2019. He expects those numbers will improve to EBITDA of $29.7-million on a topline of $109.1-million the following year.
I believe Mr Cooper is very low on 2019 revenue. Assume a growth of 8 to 10%/quarter
Q1 rev Q2. Q3. Q4. Total
$20.5. $22.5. $24. $26. $93 USD
Let's not convert to CDN since it is a weak currency and the company on due time will trade mostly on USA exchange. Assume 30% growth in 2020, revenue can be $122M USD. All organic growth.